A : Plateaus likely happen because certain neurons actively hide or destroy their own GLP-1 receptors after exposure to the drug, causing the internal cAMP signal to shut down prematurely
Because we just don't have safety data on it
Jennifer McCauley, a weight management physician at UNC Health, said Medicaid coverage of GLP-1s was incredibly helpful for our patients. Now theyve stopped coverage, so those people are now going back, regaining some of the weight, because theyre unable to obtain these medications, and also are suffering the health consequences of obesity, McCauley told Stateline
Typical patterns include: Rapid initial loss (first 4-6 weeks), much of which is water and glycogen Steady loss during mid-protocol (weeks 6-24) Plateaus lasting 1-3 weeks that resolve spontaneously Slower deceleration as you approach new equilibrium weight If you hit a plateau on tirzepatide that persists beyond 4-6 weeks at maximum dose, the tirzepatide troubleshooting guide covers the most common causes and solutions
Panel B: Methionine is the precursor of the universal methyl donor, S-adenosylmethionine (SAM)